130 related articles for article (PubMed ID: 36596345)
1. Upper-Neck Versus Whole-Neck Irradiation at the Contralateral Uninvolved Neck in Patients With Unilateral N3 Nasopharyngeal Carcinoma.
Huang CL; Qiu YY; Du XJ; Wang GY; Guo R; Zhou GQ; Liu N; Liu X; Mao YP; Sun Y; Ma J; Tang LL
Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):788-796. PubMed ID: 36596345
[TBL] [Abstract][Full Text] [Related]
2. Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial.
Tang LL; Huang CL; Zhang N; Jiang W; Wu YS; Huang SH; Mao YP; Liu Q; Li JB; Liang SQ; Qin GJ; Hu WH; Sun Y; Xie FY; Chen L; Zhou GQ; Ma J
Lancet Oncol; 2022 Apr; 23(4):479-490. PubMed ID: 35240053
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and toxicities of elective upper-neck irradiation versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: A meta-analysis.
Ding X; Cui X; Cui X; Wang S
Radiother Oncol; 2023 Nov; 188():109860. PubMed ID: 37625701
[TBL] [Abstract][Full Text] [Related]
4. A randomized clinical trial comparing prophylactic upper versus whole-neck irradiation in the treatment of patients with node-negative nasopharyngeal carcinoma.
Li JG; Yuan X; Zhang LL; Tang YQ; Liu L; Chen XD; Gong XC; Wan GF; Liao YL; Ye JM; Ao F
Cancer; 2013 Sep; 119(17):3170-6. PubMed ID: 23765713
[TBL] [Abstract][Full Text] [Related]
5. Reduced-Volume Irradiation of Uninvolved Neck in Patients With Nasopharyngeal Cancer: Updated Results From an Open-Label, Noninferiority, Multicenter, Randomized Phase III Trial.
Huang CL; Zhang N; Jiang W; Xie FY; Pei XQ; Huang SH; Wang XY; Mao YP; Li KP; Liu Q; Li JB; Liang SQ; Qin GJ; Hu WH; Zhou GQ; Ma J; Sun Y; Chen L; Tang LL
J Clin Oncol; 2024 Jun; 42(17):2021-2025. PubMed ID: 38507662
[No Abstract] [Full Text] [Related]
6. Distribution of regional lymph lode metastasis in unilateral nasopharyngeal carcinoma and the suggestions for selective prophylactic irradiation with intensity-modulated radiotherapy.
Lin F; Qiu Z; Xie D; Zhou X; Wang L; Wu Z; Cheng W; Lyu S; Su Y; Tao Y
Cancer Med; 2023 Nov; 12(21):20511-20520. PubMed ID: 37881136
[TBL] [Abstract][Full Text] [Related]
7. Evidence on Effectiveness of Upper Neck Irradiation Versus Whole Neck Irradiation as Elective Neck Irradiation in Node-Negative Nasopharyngeal Cancer: A Meta-Analysis.
Co JL; Mejia MBA; Dizon JMR
J Glob Oncol; 2018 Sep; 4():1-11. PubMed ID: 30241188
[TBL] [Abstract][Full Text] [Related]
8. The feasibility of contralateral lower neck sparing intensity modulation radiated therapy for nasopharyngeal carcinoma patients with unilateral cervical lymph node involvement.
Tang LL; Tang XR; Li WF; Chen L; Tian L; Lin AH; Sun Y; Ma J
Oral Oncol; 2017 Jun; 69():68-73. PubMed ID: 28559023
[TBL] [Abstract][Full Text] [Related]
9. Comparative study on prophylactic irradiation to the whole neck and to the upper neck for patients with neck lymph node-negative nasopharyngeal carcinoma.
Zeng L; Sun XM; Chen CY; Han F; Huang Y; Xiao WW; Liu S; Tian YM; Deng XW; Lu TX
Head Neck; 2014 May; 36(5):687-93. PubMed ID: 23606573
[TBL] [Abstract][Full Text] [Related]
10. [Prophylactic irradiation of cervical lymph nodes for Stage-N0 nasopharyngeal carcinoma].
Xie FY; Peng M; Hu WH; Han F; Wang X; Xu HM
Chin J Cancer; 2010 Jan; 29(1):106-10. PubMed ID: 20038321
[TBL] [Abstract][Full Text] [Related]
11. Upper-neck irradiation versus standard whole-neck irradiation in nasopharyngeal carcinoma: A systematic review and meta-analysis.
De Felice F; Marchetti C; Serpone M; Camarda A; Vischioni B; Ingargiola R; Musio D; Orlandi E
Tumori; 2023 Dec; 109(6):529-536. PubMed ID: 36794709
[TBL] [Abstract][Full Text] [Related]
12. [Long-term efficacy of prophylactic upper neck irradiation for stage N0 nasopharyngeal carcinoma].
Chen CZ; Li DR; Chen ZJ; Li DS; Guo LJ; Guo H
Ai Zheng; 2008 Mar; 27(3):295-8. PubMed ID: 18334120
[TBL] [Abstract][Full Text] [Related]
13. Neck level Ib-sparing versus level Ib-irradiation in intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma with high-risk factors: A propensity score-matched cohort study.
Wang G; Huang C; Yang K; Guo R; Qiu Y; Li W; Mao Y; Tang L; Ma J
Radiother Oncol; 2022 Dec; 177():205-213. PubMed ID: 36375564
[TBL] [Abstract][Full Text] [Related]
14. The feasibility of omitting irradiation to the contralateral lower neck in stage N1 nasopharyngeal carcinoma patients.
Hu W; Zhu G; Guan X; Wang X; Hu C
Radiat Oncol; 2013 Oct; 8():230. PubMed ID: 24094078
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of ipsilateral lower neck sparing irradiation for unilateral or bilateral neck node-negative nasopharyngeal carcinoma: systemic review and meta-analysis of 2, 521 patients.
Huang CL; Xu C; Zhang Y; Zhou GQ; Mao YP; Liu Q; Sun Y; Ma J; Tang LL
Radiat Oncol; 2018 Aug; 13(1):141. PubMed ID: 30081932
[TBL] [Abstract][Full Text] [Related]
16. Prognosis and staging of parotid lymph node metastasis in nasopharyngeal carcinoma: An analysis in 10,126 patients.
Zhang Y; Zhang ZC; Li WF; Liu X; Liu Q; Ma J
Oral Oncol; 2019 Aug; 95():150-156. PubMed ID: 31345383
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the feasibility of elective irradiation to neck level Ib using intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma: a retrospective analysis.
Zhang F; Cheng YK; Li WF; Guo R; Chen L; Sun Y; Mao YP; Zhou GQ; Liu X; Liu LZ; Lin AH; Tang LL; Ma J
BMC Cancer; 2015 Oct; 15():709. PubMed ID: 26472233
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy in locally advanced nasopharyngeal carcinoma: Comparative study at SKIMS Tertiary Care Institute.
Fatima K; Andleeb A; Sofi MA; Rasool MT; Fir A; Nasreen S; Dar NA
J Cancer Res Ther; 2022; 18(1):133-139. PubMed ID: 35381774
[TBL] [Abstract][Full Text] [Related]
19. Sparing level Ib lymph nodes by intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma.
Chen J; Ou D; He X; Hu C
Int J Clin Oncol; 2014 Dec; 19(6):998-1004. PubMed ID: 24337503
[TBL] [Abstract][Full Text] [Related]
20. A comparison of cisplatin cumulative dose and cisplatin schedule in patients treated with concurrent chemo-radiotherapy in nasopharyngeal carcinoma.
Gundog M; Basaran H; Bozkurt O; Eroglu C
Braz J Otorhinolaryngol; 2020; 86(6):676-686. PubMed ID: 31164277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
